Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Investing is vital for financial growth, allowing your money to work for you. Explore the benefits of starting your investment journey.
26,804 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Uber's top executive forecasts a future where autonomous taxis handle the bulk of trips within two decades, a scenari...
Flux, a hardware-software startup, raised $37 million in a round led by 8VC to accelerate a browser-based electronics...
A prominent oil strategist argues the Iran war premium is inflating prices, suggesting oil could trade in the $40s if...
Redwood Trust closed a $391 million securitization backed by non-qualified mortgages, the inaugural deal under its ex...
NVIDIA unveils a major push into AI infrastructure, backing key optics and photonics partners to speed AI inference. ...
Oil climbs to the upper $90s per barrel as defense spending expands and aviation MRO demand stays tight. Analysts say...
Shiba Inu showed a notable, double-digit climb this week. This guide breaks down the catalysts—ecosystem upgrades, se...
Hyperliquid’s HIP-3 markets surged to $1.43 billion in open interest, driven by around-the-clock tokenized asset trad...
Energy costs are climbing in early 2026 and are expected to ripple through U.S. supply chains, pressuring prices on g...
Oil prices fall, stock futures rise as reports of a U.S.-backed cease-fire plan with Iran surface, setting up a cauti...
A new survey of 351 institutions finds 25% intend to add XRP in 2026, joining the 18% already holding the token. Pric...